Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates



@@#116300@@

Joint Bone Spine
Sous presse. Epreuves corrigées par l'auteur. Disponible en ligne depuis le jeudi 29 mars 2012
Doi : 10.1016/j.jbspin.2011.10.015
accepted : 14 October 2011
Hemophagocytic lymphohistiocytosis in adults: Diagnosis and treatment
 

Claire Larroche
Service de médecine interne, université Paris-XIII, CHU Avicenne, 125, rue de Stalingrad, 93009 Bobigny cedex, France 

Tel.: +33 1 48 95 53 51; fax: +33 1 48 95 54 50.
Abstract

Hemophagocytic lymphohistiocytosis occurring as a primary or acquired disorder is a condition of chaotic and uncontrolled immune system stimulation. Cytotoxic cells and macrophages cause multiorgan damage, hemophagocytosis, and severe systemic inflammation. Clinical manifestations include a fever, organ enlargement, and weight loss. Laboratory tests show bicytopenia or pancytopenia, cytolysis and cholestasis, serum ferritin elevation, and clotting disorders. The reference standard for the diagnosis remains the presence in histological specimens of hemophagocytic macrophages, which may be lacking early in the disease, leading to diagnostic challenges. Inherited forms produce symptoms in early childhood and are fatal in the absence of specific treatment. In adults, the clinical spectrum ranges from mild and self-limited hemophagocytic lymphohistiocytosis to rapidly fatal multiorgan failure. Many questions remain unresolved regarding the diagnosis and treatment in adults. This update is an attempt at providing answers.


Keywords : Macrophage activation syndrome, Hemophagocytic lymphohistiocytosis




© 2011  Société française de rhumatologie@@#104156@@